His research studies focus on B-cell lymphoproliferative disorders, investigating the interaction of the tumor clone with the bone marrow milieu, in addition to pre-clinical drug validation. He is the author of more than 170 manuscripts published in international scientific journals, including Blood, JCI, JCO, PNAS, Cancer Res, Clin Cancer Res, Cell Reports, Science Advances, to cite a few. Characterized by their translational value, the studies conducted over the years have allowed the initiation of numerous clinical trials for the treatment of patients with relapsed / refractory multiple myeloma and Waldenstrom Macroglobulinemia.

He is the Principal Investigator of research grants funded by European Union, European Hematology Association, Italian Foundation for Cancer Research, Int’l Waldenstrom Macrogloglobulinemia Foundation. Ad hoc reviewer for Blood, Lancet Hematology, Nat Communications, Haematologica.